NOVEL TARGETS AND THERAPIES IN MULTIPLE MYELOMA
Multiple Myeloma (MM) is the second most frequent cancer and constitutes 10 % of hematological malignancies. Median age at onset is older than 65 years old.Despite significant improvement has been gained for management of the diasease in the last decades cure has not been achieved. Clinicial use of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029341 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!